Theivanthiran et al. highlighted the role played by PD-L1 associated with the inflammasome to drive granulocytic MDSC recruitment into the tumor, which caused resistance to PD-1 blockade immunotherapy [141]. The gene discussed is PDCD1; the disease is neoplasm.